Global Meningitis Diagnostic Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Meningitis Diagnostic Testing Market is presumed to reach the market size of nearly USD 353.77 MN by 2030 from USD 209 MN in 2022 with a CAGR of 6.8% under the study period 2023 - 2030.

Meningitis is an inflammation of membranes called meninges surrounding the brain and spinal cord. Bacteria, viruses, parasites, and fungi cause this infection. Due to its propensity to spread like an epidemic, meningitis has become a topic of worry on a global scale. As a result, the government is actively working to eradicate meningitis by setting up high-tech diagnostic facilities and hospitals to provide patient care. Meningitis is diagnosed using a fast latex agglutination test or extremely sophisticated PCR, immunoassay, and other testing equipment.

Market Dynamics:

The market is expected to rise due to increased consumer awareness of the need for early disease detection, rising demand for quick diagnoses, and high test accuracy. Additionally, the growing number of diagnostic facilities and government funding to lessen disease burden drive market demand. Furthermore, the meningitis diagnostic market's development is fueled by new cutting-edge technologies like PCR and next-generation sequencing that offer a less expensive diagnosis. During the projection period, several issues, including a lack of diagnostic laboratory facilities in emerging nations and a scarcity of specialists in meningitis diagnosis, are projected to restrain market expansion.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of meningitis diagnostic testing. The growth and trends of meningitis diagnostic testing industry provide a holistic approach to this study.

Market Segmentation:

This section of the meningitis diagnostic testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

Latex Agglutination Tests
Lateral Flow Assay
PCR Assay
ELISA Tests
Culture Test
Others

By End-User

Hospitals
Diagnostic Centers
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Meningitis Diagnostic Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the meningitis diagnostic testing market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Abbott, ELITechGroup, Seegene Inc., Luminex Corporation, Certest Biotec, IMMY, Uniogen Oy. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR112110129

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . MENINGITIS DIAGNOSTIC TESTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Test Type
- 3.7.2 Market Attractiveness Analysis By End-User
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET ANALYSIS BY TEST TYPE

6.1 Overview by Test Type
6.2 Historical and Forecast Data
6.3 Analysis by Test Type
6.4 Latex Agglutination Tests Historic and Forecast Sales by Regions
6.5 Lateral Flow Assay Historic and Forecast Sales by Regions
6.6 PCR Assay Historic and Forecast Sales by Regions
6.7 ELISA Tests Historic and Forecast Sales by Regions
6.8 Culture Test Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET ANALYSIS BY END-USER

7.1 Overview by End-User
7.2 Historical and Forecast Data
7.3 Analysis by End-User
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Diagnostic Centers Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MENINGITIS DIAGNOSTIC TESTING COMPANIES

9.1. Meningitis Diagnostic Testing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF MENINGITIS DIAGNOSTIC TESTING INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Bio-Rad Laboratories Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Abbott
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. ELITechGroup
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Seegene Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Luminex Corporation
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Certest Biotec
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. IMMY
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Uniogen Oy
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies